CD4 and myeloid sarcoma: Supporting this, NH patients also displayed an increased frequency of GM-CSF–producing CD4+ and CD8+ T cells, which have been implicated in the activation of innate immune cells and correlate with MS disease activity, as high blood and CSF levels associate with worse outcomes (40, 41).